Hormi et al. [79] reported that the use of a specific MCL-1 inhibitor (S63845) in combination with venetoclax induced apoptosis in AML cells, and such a response was also detected in venetoclax-resistant AML cells. This evidence concerns the gene MCL1 and acute myeloid leukemia.